Baldovin, T.; Leoni, D.; Geppini, R.; Miatton, A.; Amoruso, I.; Fonzo, M.; Bertoncello, C.; Finco, M.; Mazzitelli, M.; Sasset, L.;
et al. Immunogenicity and Determinants of Antibody Response to the BNT162b2 mRNA Vaccine: A Longitudinal Study in a Cohort of People Living with HIV. Vaccines 2024, 12, 1172.
https://doi.org/10.3390/vaccines12101172
AMA Style
Baldovin T, Leoni D, Geppini R, Miatton A, Amoruso I, Fonzo M, Bertoncello C, Finco M, Mazzitelli M, Sasset L,
et al. Immunogenicity and Determinants of Antibody Response to the BNT162b2 mRNA Vaccine: A Longitudinal Study in a Cohort of People Living with HIV. Vaccines. 2024; 12(10):1172.
https://doi.org/10.3390/vaccines12101172
Chicago/Turabian Style
Baldovin, Tatjana, Davide Leoni, Ruggero Geppini, Andrea Miatton, Irene Amoruso, Marco Fonzo, Chiara Bertoncello, Mascia Finco, Maria Mazzitelli, Lolita Sasset,
and et al. 2024. "Immunogenicity and Determinants of Antibody Response to the BNT162b2 mRNA Vaccine: A Longitudinal Study in a Cohort of People Living with HIV" Vaccines 12, no. 10: 1172.
https://doi.org/10.3390/vaccines12101172
APA Style
Baldovin, T., Leoni, D., Geppini, R., Miatton, A., Amoruso, I., Fonzo, M., Bertoncello, C., Finco, M., Mazzitelli, M., Sasset, L., Cattelan, A., & Baldo, V.
(2024). Immunogenicity and Determinants of Antibody Response to the BNT162b2 mRNA Vaccine: A Longitudinal Study in a Cohort of People Living with HIV. Vaccines, 12(10), 1172.
https://doi.org/10.3390/vaccines12101172
